Table 4. In vivo pharmacokinetic characterization of 29 in mice.
29
|
||
3 mg kg–1 IV a | 25 mg kg–1 p.o. b | |
C max (μM) | 2.8 | |
AUClast (μM h) | 2.3 | 5.1 |
t 1/2 (h) | 5.0 | 1.0 |
Cl (mL min–1 kg–1) | 45 | |
V ss (L kg–1) | 6.3 | |
F | 27% |
a5% DMAC/76% PEG400/19% water; Balb/C; male.
b5% DMAC/9.5% EtOH/76% PEG300/9.5% TPGS; Balb/C; male.21